News

CoreWeave's stock price has been trading lower since its IPO due to concerns about its financials and weaker-than-expected demand. Despite the weak debut, the company has secured key partnerships and some analysts see potential for growth if it can leverage its relationships to expand its high-performance computing services.

Virax Biolabs, a UK-based company specializing in immune response detection and viral disease diagnosis, is making significant strides in developing T cell-based test technologies for post-viral syndromes like Long COVID. These tests hold promise for diagnosing and treating these debilitating conditions, which affect millions of people worldwide.

Red Cat Holdings Inc. announced its 2024 transition period financial results, highlighting a total revenue of $4.9 million and an earnings loss of 57 cents per share. The company also shared an ambitious outlook for 2025, driven by international market expansion and increased production capacity funded by additional non-dilutive financing.

U.S. President Donald Trump is poised to unveil his broadest tariff initiative yet, with the measures expected to take effect on April 2, a day he has termed “Liberation Day.” The plan, designed to counteract what is seen as unfair trade practices by imposing reciprocal tariffs on specific nations, has stirred market uncertainty as officials hint at targeting key trading partners responsible for significant trade imbalances.

The Trump family has significantly increased its control over World Liberty Financial, a decentralized finance platform still under development, by establishing a new parent company that gives them majority ownership and control over the platform's development and governance. This move raises concerns about potential influence or corruption, as the Trump family now holds substantial control over both the platform and its financial outcomes.